FORMOTEROL

SynDRA canonical compound SYN0024697 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ADRB2 \| CYP2C19
Mechanism of action	adrenergic receptor agonist
Indication	asthma \| bronchospasm \| chronic obstructive pulmonary disease (COPD)
Disease area	pulmonary

All known targets

eformoterol
formoterol fumarate
formoterol fumarate dihydrate
formoterol fumarate hydrate
Oxis
Foradile
Formoterol tartrate
Oxeze Turbuhaler Foradil
MOLI000351
Atimos (TN)
Atock (TN)
Foradil (TN)
Foradile (TN)
Formoterol (INN)
Modulite (TN)
Oxeze (TN)
Oxis (TN)
Perforomist (TN)
Formoterol, ((R*,R*)-(+-)-)-isomer
N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide
N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide
N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
(+-)-2'-Hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide
3-formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate
5ZZ84GCW8B
Eformoterol
Formoterolum
(+-)-Formoterol
RefChem:5843
CHEBI:5147
DTXCID4065311
R03AC13
Formoterolum [INN-Latin]
Oxeze/Oxis
Formoterol Impurity 109
NCGC00181126-01
SCHEMBL349579
GTPL3465